Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26


Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.

Chen YH, Grigelioniene G, Newton PT, Gullander J, Elfving M, Hammarsjö A, Batkovskyte D, Alsaif HS, Kurdi WIY, Abdulwahab F, Shanmugasundaram V, Devey L, Bacrot S, Brodszki J, Huber C, Hamel B, Gisselsson D, Papadogiannakis N, Jedrycha K, Gürtl-Lackner B, Chagin AS, Nishimura G, Aschenbrenner D, Alkuraya FS, Laurence A, Cormier-Daire V, Uhlig HH.

J Exp Med. 2020 Mar 2;217(3). pii: e20191306. doi: 10.1084/jem.20191306.


Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study.

Mokry LE, Zhou S, Guo C, Scott RA, Devey L, Langenberg C, Wareham N, Waterworth D, Cardon L, Sanseau P, Davey Smith G, Richards JB.

Sci Rep. 2019 Jun 28;9(1):9386. doi: 10.1038/s41598-019-45747-2.


A molecular signature for delayed graft function.

McGuinness D, Mohammed S, Monaghan L, Wilson PA, Kingsmore DB, Shapter O, Stevenson KS, Coley SM, Devey L, Kirkpatrick RB, Shiels PG.

Aging Cell. 2018 Oct;17(5):e12825. doi: 10.1111/acel.12825. Epub 2018 Aug 9.


Can a Software-Based Metronome Tool Enhance Compression Rate in a Realistic 911 Call Scenario Without Adversely Impacting Compression Depth for Dispatcher-Assisted CPR?

Scott G, Barron T, Gardett I, Broadbent M, Downs H, Devey L, Hinterman EJ, Clawson J, Olola C.

Prehosp Disaster Med. 2018 Aug;33(4):399-405. doi: 10.1017/S1049023X18000602. Epub 2018 Jul 23.


Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.

Banham GD, Flint SM, Torpey N, Lyons PA, Shanahan DN, Gibson A, Watson CJE, O'Sullivan AM, Chadwick JA, Foster KE, Jones RB, Devey LR, Richards A, Erwig LP, Savage CO, Smith KGC, Henderson RB, Clatworthy MR.

Lancet. 2018 Jun 30;391(10140):2619-2630. doi: 10.1016/S0140-6736(18)30984-X. Epub 2018 Jun 14.


Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.

Zuk A, Palevsky PM, Fried L, Harrell FE Jr, Khan S, McKay DB, Devey L, Chawla L, de Caestecker M, Kaufman JS, Thompson BT, Agarwal A, Greene T, Okusa MD, Bonventre JV, Dember LM, Liu KD, Humphreys BD, Gossett D, Xie Y, Norton JM, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1113-1123. doi: 10.2215/CJN.06820617. Epub 2018 Mar 9.


Use of Renal Replacement Therapy May Influence Graft Outcomes following Liver Transplantation for Acute Liver Failure: A Propensity-Score Matched Population-Based Retrospective Cohort Study.

Knight SR, Oniscu GC, Devey L, Simpson KJ, Wigmore SJ, Harrison EM.

PLoS One. 2016 Mar 1;11(3):e0148782. doi: 10.1371/journal.pone.0148782. eCollection 2016.


CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure.

Stutchfield BM, Antoine DJ, Mackinnon AC, Gow DJ, Bain CC, Hawley CA, Hughes MJ, Francis B, Wojtacha D, Man TY, Dear JW, Devey LR, Mowat AM, Pollard JW, Park BK, Jenkins SJ, Simpson KJ, Hume DA, Wigmore SJ, Forbes SJ.

Gastroenterology. 2015 Dec;149(7):1896-1909.e14. doi: 10.1053/j.gastro.2015.08.053. Epub 2015 Sep 5.


Ischemic preconditioning in the liver is independent of regulatory T cell activity.

Devey LR, Richards JA, O'Connor RA, Borthwick G, Clay S, Howie AF, Wigmore SJ, Anderton SM, Howie SE.

PLoS One. 2012;7(11):e49647. doi: 10.1371/journal.pone.0049647. Epub 2012 Nov 21.


Heme oxygenase system in hepatic ischemia-reperfusion injury.

Richards JA, Wigmore SJ, Devey LR.

World J Gastroenterol. 2010 Dec 28;16(48):6068-78.


c-Jun terminal kinase-2 gene deleted mice overexpress hemeoxygenase-1 and are protected from hepatic ischemia reperfusion injury.

Devey L, Mohr E, Bellamy C, Simpson K, Henderson N, Harrison EM, Ross JA, Wigmore SJ.

Transplantation. 2009 Aug 15;88(3):308-16. doi: 10.1097/TP.0b013e3181ae3067.


Non-heart-beating organ donation.

Devey L, Wigmore SJ.

Br J Surg. 2009 Aug;96(8):833-5. doi: 10.1002/bjs.6703. No abstract available.


Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism.

Devey L, Ferenbach D, Mohr E, Sangster K, Bellamy CO, Hughes J, Wigmore SJ.

Mol Ther. 2009 Jan;17(1):65-72. doi: 10.1038/mt.2008.237. Epub 2008 Nov 11.


Heat shock protein 90-binding agents protect renal cells from oxidative stress and reduce kidney ischemia-reperfusion injury.

Harrison EM, Sharpe E, Bellamy CO, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ.

Am J Physiol Renal Physiol. 2008 Aug;295(2):F397-405. doi: 10.1152/ajprenal.00361.2007. Epub 2008 Jun 18.


Effect of temperature control upon a mouse model of partial hepatic ischaemia/reperfusion injury.

Devey L, Festing MF, Wigmore SJ.

Lab Anim. 2008 Jan;42(1):12-8. doi: 10.1258/la.2007.06009e.


The use of marginal heart beating donor livers for transplantation in the United kingdom.

Devey LR, Friend PJ, Forsythe JL, Mumford LL, Wigmore SJ.

Transplantation. 2007 Jul 15;84(1):70-4.


Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A.

Circulation. 2007 Apr 3;115(13):1789-97. Epub 2007 Mar 26.


Pretransplant bilirubin concentration does not correlate with early reperfusion injury following liver transplantation.

Manzinate F, McDaid J, Devey L, Gunson B, Wigmore SJ.

Transplantation. 2007 Jan 15;83(1):103-4. No abstract available.


Is death the price of tolerance?

Devey LR, Wigmore SJ.

Transplantation. 2006 Dec 15;82(11):1411-2. No abstract available.


Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in renal cells.

Harrison EM, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ.

FEBS J. 2006 Jun;273(11):2345-56.

Supplemental Content

Support Center